Century Therapeutics, Inc. (IPSC) has 55 open-market insider trades by 11 insiders since 2021. Over the last six months insiders net sold $22K. The most active filer is Douglas Carr, VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Aktiengesellschaft Bayer | 10% Owner | — | 1 | $15.0M | 2021-06-22 |
| Eli Casdin | Dir | — | 1 | $15.0M | 2021-06-22 |
| Versant Vantage II GP, L.P. | 10% Owner | — | 1 | $7.2M | 2022-08-09 |
| Versant Vantage II, L.P. | 10% Owner | — | 1 | $2.0M | 2021-12-23 |
| Luis Borges | CSO | — | 1 | $1.1M | 2023-04-03 |
| Adrienne Farid | COO | — | 9 | $295K | 2025-06-09 |
| Brent Pfeiffenberger | CEOPres | — | 8 | $108K | 2026-09-11 |
| Chad Cowan | CSO | — | 2 | $52K | 2026-06-11 |
| Gregory Russotti | — | — | 10 | $42K | 2026-09-14 |
| Douglas Carr | VP | — | 20 | $39K | 2026-09-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Douglas Carr | VP | Sell | $3K | 2026-09-14 |
| Gregory Russotti | — | Sell | $5K | 2026-09-14 |
| Gregory Russotti | — | Sell | $1K | 2026-09-08 |
| Douglas Carr | VP | Sell | $521 | 2026-09-08 |
| Douglas Carr | VP | Sell | $4K | 2026-06-12 |
| Gregory Russotti | — | Sell | $6K | 2026-06-12 |
Companies that share insiders with IPSC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Douglas Carr | VP | Sell | $526 | 2026-06-08 |
| Gregory Russotti | — | Sell | $1K | 2026-06-08 |
| Douglas Carr | VP | Sell | $618 | 2026-05-04 |
| Gregory Russotti | — | Sell | $26K | 2026-03-12 |
| Douglas Carr | VP | Sell | $18K | 2026-03-12 |
| Douglas Carr | SVP Finance & Operations | Sell | $626 | 2026-03-09 |
| Gregory Russotti | — | Sell | $1K | 2026-03-09 |
| Douglas Carr | SVP Finance & Operations | Sell | $588 | 2026-02-03 |
| Chad Cowan | Chief Scientific Officer | Buy | $49K | 2025-12-22 |